| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Departments of Internal Medicine (O.P., V.C., M.M., E.D.N., G.F.) and Biopathology and Diagnostic Imaging (E.G.), University of Rome "Tor Vergata," 00133 Rome, Italy; Immunogenetics Laboratory (M.A., M.T.), Mediterranean Institute of Hematology (MIH) Foundation, 00133 Rome, Italy; Endocrinology and Diabetology Unit and Research Laboratory (M.C., G.F.), Bambino Gesù Childrens Hospital, 00165 Rome, Italy; and Division of Paediatrics B. Trambusti (A.A., L.C.), University of Bari, 70126 Bari, Italy
Address all correspondence and requests for reprints to: Ottavia Porzio, M.D., Department of Internal Medicine, University of Rome "Tor Vergata," Via di Montpellier 1, 00133 Rome, Italy. E-mail: porzio{at}uniroma2.it.
Context: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders most often caused by enzyme 21-hydroxylase deficiency. Most mutations causing enzymatic deficiency are generated by recombinations between the active gene CYP21 and the pseudogene CYP21P. Only 12% of affected alleles result from spontaneous mutations. The phenotype of CAH varies greatly, usually classified as classical or nonclassical, depending on variable degree in 21-hydroxylase activity. Here we report a divergent phenotype of two human leukocyte antigen identical siblings, affected by nonclassical and classical CAH caused by 21-hydroxylase deficiency due to different genotype.
Patients and Methods: Using direct sequencing method and Southern blot, we studied two children (one male and one female), affected, respectively, by nonclassical and classical CAH and their parents.
Results: The mother was heterozygous for the Q318X mutation, and the father was heterozygous for the V281L mutation. The brother was a compound heterozygote for the mutations V281L and Q318X, whereas the proband was compound heterozygote for the Q318X mutation and a large conversion. The two children are human leukocyte antigen identical (A*02;B*14;DRB1*01/A*33;B*14;DRB1*03).
Conclusions: Different phenotype of the proband is the result of compound heterozygosity for the maternal mutation Q318X and a de novo large conversion.
This article has been cited by other articles:
![]() |
S. M. Baumgartner-Parzer, G. Fischer, and H. Vierhapper Predisposition for de Novo Gene Aberrations in the Offspring of Mothers with a Duplicated CYP21A2 Gene J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1164 - 1167. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |